Fil d'Ariane


Outils web COMPAR-EU

MRC is a validated measure of disease severity (irrespective of patient's FEV1). It is also used to determine eligibility for Pulmonary Rehab service (those with an MRC Grade of 3, 4 or 5 can be referred). Frequent exacerbations. This scale measures perceived respiratory disability, it is simple to administer as it allows the patients to indicate the extent to which their breathlessness affects their mobility. They range from stage 1 to 5.
Year: 2013 Authors: Thompson et al Disease: COPD Outcome: COPD symptoms (short term)
See more tools that use this outcome
Measure: Dyspnea or breathlessness
See more tools that use this measure
Number of RCTs that used this tool (in our study): 14
See the RCTs
Scale: Lower scores are better, scores range 1-5 Reference: Thompson, A. G., Lowe, J., Fox, Z., Lukic, A., Porter, M. C., Ford, L., Gorham, M., Gopalakrishnan, G. S., Rudge, P., Walker, A. S., Collinge, J., & Mead, S. (2013). The Medical Research Council prion disease rating scale: a new outcome measure for prion disease therapeutic trials developed and validated using systematic observational studies. Brain : a journal of neurology, 136(Pt 4), 1116–1127.
Target population: General population Focus Disease specific Translations available: Yes Original version validated: Yes Original language: English Form of delivery: Self-reported Licence needed: Yes 10.1093/brain/awt048

Related RCTs